title: Exercise in patients with hypertrophic cardiomyopathy: A review of current evidence, national guideline recommendations and a proposal for a new direction to fitness.
abstract: Hypertrophic cardiomyopathy is a common genetic disorder with a prevalence of 1:500 in the general population. Amongst a varied spectrum of clinical presentations, the most feared complication of this cardiac disorder is sudden cardiac death. Although only a minority of patients with hypertrophic cardiomyopathy who suffer sudden cardiac death or resuscitated cardiac arrest do so during exercise, strenuous physical activity is regarded as an important trigger for these tragic outcomes. Furthermore, during exercise, patients with hypertrophic cardiomyopathy may develop augmentation of left ventricular outflow tract obstruction, myocardial ischemia, diastolic dysfunction and/or inappropriate vasodilation in non-exercising vascular beds. This in turn may lead to exertional dyspnea, chest pain or syncope. Accordingly, patients with hypertrophic cardiomyopathy are disqualified from competitive sports and in many cases are recommended to avoid strenuous physical activity of any kind. Nevertheless, avoidance of physical activity comes with a price. The positive effects of regular exercise have been extensively reported to convey a wide range of benefits including reduced cardiovascular events, weight reduction and improved wellbeing. Therefore, finding the right exercise level that will offer some of the benefits of physical activity without increasing the risk of sudden cardiac death is of utmost importance. In this review, we discuss the current evidence for and against exercise in this patient population and review national guideline recommendations. We also propose alternative fitness strategies including a novel fitness program implemented by our hypertrophic cardiomyopathy center which may be of particular usefulness for hypertrophic cardiomyopathy patients.
authors.affiliation: Department of Medicine, University of Toronto, Canada.
authors.forename: Waseem
authors.initials: W
authors.lastname: Hindieh
authors.affiliation: Department of Medicine, University of Toronto, Canada.
authors.forename: Arnon
authors.initials: A
authors.lastname: Adler
authors.affiliation: Department of Medicine, University of Toronto, Canada.
authors.forename: Adaya
authors.initials: A
authors.lastname: Weissler-Snir
authors.affiliation: Department of Medicine, University of Toronto, Canada.
authors.forename: Dana
authors.initials: D
authors.lastname: Fourey
authors.affiliation: Department of Medicine, University of Toronto, Canada.
authors.forename: Sarah
authors.initials: S
authors.lastname: Harris
authors.affiliation: Department of Medicine, University of Toronto, Canada. Electronic address: harry.rakowski@uhn.on.ca.
authors.forename: Harry
authors.initials: H
authors.lastname: Rakowski
mesh_terms: D002312:Cardiomyopathy, Hypertrophic / Q000150:complications / Q000503:physiopathology*; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control*; D004452:Echocardiography; D015444:Exercise; D005081:Exercise Therapy / Q000379:methods; D017408:Guidelines as Topic; D006801:Humans; D012306:Risk; D013177:Sports
keywords: Exercise; Hypertrophic cardiomyopathy; Left ventricular outflow tract obstruction; Sudden cardiac death